The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result-Reference-Cited by-同舟云学术

The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result

Published:2015-05-28 Issue:8 Volume:111 Page:935-940
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Alvarado Michael¹,Carter Dennis L.²,Guenther J. Michael³,Hagans James⁴,Lei Rachel Y.²,Leonard Charles E.⁵,Manders Jennifer⁶,Sing Amy P.⁷,Broder Michael S.⁸,Cherepanov Dasha⁸,Chang Eunice⁸,Eagan Marianne⁸,Hsiao Wendy⁹,Schultz Michael J.¹⁰

Affiliation:

1. University of California; San Francisco California

2. Rocky Mountain Cancer Centers; Aurora Colorado

3. St. Elizabeth Healthcare; Edgewood Kentucky

4. The Surgical Center of Central Arkansas; Little Rock Arkansas

5. Rocky Mountain Cancer Centers; Littleton Colorado

6. The Christ Hospital; Cincinnati Ohio

7. Genomic Health, Inc.; Redwood City California

8. Partnership for Health Analytic Research, LLC; Beverly Hills California

9. University of Southern California; Los Angeles California

10. University of Maryland St. Joseph Medical Center; Towson Maryland

Funder